Additionally, increased PAD4 expression has been observed in the blood and tissues of patients with malignant tumors, and these elevated PAD4 levels were significantly associated with high thrombin activity caused by citrullinated antithrombin [123]. The gene discussed is PADI4; the disease is cancer.